US FDA approves Merck's RSV antibody for infants

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/4/2026

1. PLTR
2. SNAP
3. SKHY
4. SPY
5. INSP
6. JAZZ
7. SPCX
8. ON
9. THRY
10. TKO

Go back to US FDA approves Merck's RSV antibody for infants
Merck & Co. (NYSE: MRK) Delayed: 128.00 +0.23 (0.18%)
Previous Close $127.77    52 Week High $65.46 
Open $128.46    52 Week Low $47.97 
Day High $129.99    P/E 87.07 
Day Low $126.22    EPS $1.47 
Volume 10,743,304